Sukumar Nagendran - 06 Jun 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Issuer symbol: SLDB
Report date: 06 Jun 2023
Net transaction value: $0
Form type: 4
Accepted by SEC: 08 Jun 2023, 21:19:49 UTC
Previous filing: 18 May 2023
Next filing: 18 Dec 2023
SEC filing: View on sec.gov
Reporting owner signature: /s/ David Tyronne Howton as attorney-in-fact for Sukumar Nagendran

Key filing fact

Sukumar Nagendran filed Form 4 for Solid Biosciences Inc. (SLDB) on 08 Jun 2023.

Key facts

This page summarizes Sukumar Nagendran's Form 4 filing for Solid Biosciences Inc. (SLDB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2023, 21:19.

Change

Previous filing in this sequence was filed on 18 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +9,650
Change %
Price: $0.000000
Shares after: 9,650
Date: 06 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,650
Exercise price: $6.37
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.